+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Application of allogeneic mesenchymal stem cells in complex patients treatment with ulcerative colitis

Application of allogeneic mesenchymal stem cells in complex patients treatment with ulcerative colitis

Eksperimental'naia i Klinicheskaia Gastroenterologiia 2009(5): 4-12

Systemic transplantation of mesenchymal stem cells (MSC) is known to promote reparative process in a number of tissue damage as well as mucous healing one. It provided the basis for our study which was aimed to the effect of systemic transplantation of allogenic MSC (intravenous transfusion) in complex therapy of patients with Ulcerative Colitis.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 051607975

Download citation: RISBibTeXText

PMID: 20205326

Related references

The successful application of allogeneic mesenchymal stem cells in a patient with ulcerative colitis. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2009(4): 112-115, 2009

Pharmacoeconomic benefits of patients with ulcerative colitis treatment with help of mesenchymal stem cells. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2010(3): 51-59, 2010

Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation. Eksperimental'naia i Klinicheskaia Gastroenterologiia 11): 3-15, 2011

Transplantation of allogeneic mesenchymal stem cells from the bone marrow increases duration of remission and reduces the risk of ulcerative colitis relapse. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2010(3): 5-10, 2010

Su1733 Influence of Mesenchymal Stem Cells on Morphological Reparation of Intestinal Mucosa in Experiments and in Patients With Ulcerative Colitis. Gastroenterology 144(5): S-463, 2013

Age as a prognostic factor in the treatment effectiveness of patients with ulcerative colitis with help of mesenchymal stromal cells. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2010(12): 3-9, 2010

Use of mesenchymal stem cells in the combination therapy of ulcerative colitis. Terapevticheskii Arkhiv 88(2): 44-48, 2016

Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. Blood Cells Molecules and Diseases 40(1): 25-32, 2008

Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty. Oncotarget 7(11): 11899-11912, 2016

Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis. Stem Cell Research and Therapy 6: 263, 2015

Transplantation of Mesenchymal Stem Cells reduces the risk of recurrence of Ulcerative Colitis after the first attack. Inflammatory Bowel Diseases 17: S25-S26, 2011

Inhibition of in vitro cytotoxicity of lymphocytes from patients with ulcerative colitis and granulomatous colitis for allogeneic colonic epithelial cells using horse anti-human thymus serum. Gastroenterology 54(2): 227-231, 1968

Combinatorial Intervention with Mesenchymal Stem Cells and Granulocyte Colony-Stimulating Factor in a Rat Model of Ulcerative Colitis. Digestive Diseases and Sciences 60(7): 1948-1957, 2015

Cotransplantation of haploidentical hematopoietic stem cells and allogeneic bone marrow-derived mesenchymal stromal cells as a first-line treatment in very severe aplastic anemia patients with refractory infections. European Journal of Haematology 100(6): 624-629, 2018

Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses. Frontiers in Veterinary Science 4: 158, 2017